Cost and Utilization of Inpatient Mental Health and Substance Use Treatment

• by Lynne Cotter, Nirmita Panchal, Gary Claxton, Justin Lo

• June 29, 2026

Long-Term Opioid Therapy Tapering and Risk of Substance Use Disorder and Overdose: Differences by Opioid Dose and Duration

• by Patrick D. Quinn, Richard Meraz, Olena Mazurenko, Zheng Chang, Arvid Sjölander, Austin R. Medlin, Adam T. Hirsh, Toyya A. Pujol, Kurt Kroenke, Brian M. D’Onofrio

• June 24, 2026

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.

• by Kathryn Wighton

• June 22, 2026

• 3 min

Error in the Text

• June 1, 2026